Autopsy report · NCT00113503

Imuran Dosing in Crohn's Disease Study

“Insufficient enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 2 years 5 months before it stopped.
• 50 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sponsor type

US National Institutes of Health

Conditions

Crohn's Disease

Interventions

Azathioprine weight-based dose; Azathioprine individualised dose

Participants

50

Sites

15

Countries

Canada, United States

Trials that died the same way

• Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma
  “Insufficient enrollment rate” (91% match in meaning)
• Treatment Prior to Injection and Biopsy of the Vulva
  “Not enough enrollment” (91% match in meaning)
• Family Nurture Intervention in the CHoNJ NICU
  “insufficient enrollment numbers” (91% match in meaning)
• Development of Auditory Skills in Young Deaf Children With Bilateral Cochlear Implants
  “Not sufficient enrollment” (89% match in meaning)
• C Tracker, Hepatitis C, Care & Collaboration - Patient Reported Outcomes Survey Study
  “Lack of enrollment” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.